Samir Parekh

Search results

• MMRF awards $21 million for multiple myeloma research networks

  Samir Parekh

  7/11/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation

  Samir Parekh, Brian Brown & Sundar Jagannath

  6/11/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation

  Samir Parekh, Brian Brown & Sundar Jagannath

  2/11/23 → 3/11/23

  2 items of Media coverage

  Press/Media

• The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks

  Samir Parekh

  2/11/23

  1 item of Media coverage

  Press/Media

• The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks

  Samir Parekh

  2/11/23

  7 items of Media coverage

  Press/Media

• Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation

  Samir Parekh, Brian Brown & Sundar Jagannath

  2/11/23

  26 items of Media coverage

  Press/Media

• The Multiple Myeloma Research Foundation Announces $21M Grant Program to Support Multicenter Translational Research Networks

  Samir Parekh

  2/11/23

  1 item of Media coverage

  Press/Media

• Diabetes Fuels Multiple Myeloma Growth, Affects Survival Rates Differently Across Races: Study

  Samir Parekh

  3/10/23

  1 item of Media coverage

  Press/Media

• News Diabetes Linked to Worse Blood Cancer Survival A first-of-its-kind study unveils how diabetes drives multiple myeloma growth and differences in survival outcomes for Black versus white patients with both conditions.

  Samir Parekh & Emily Gallagher

  2/10/23

  1 item of Media coverage

  Press/Media

• Racial Disparities in Diabetes' Impact on Blood Cancer Growth

  Samir Parekh & Emily Gallagher

  30/09/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Hospital: Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race

  Samir Parekh & Emily Gallagher

  30/09/23

  1 item of Media coverage

  Press/Media

• Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race

  Samir Parekh & Emily Gallagher

  29/09/23

  1 item of Media coverage

  Press/Media

• Mount Sinai Health System: Diabetes May Accelerate Blood Cancer Growth, Yet Survival Outcomes Differ by Race

  Samir Parekh & Emily Gallagher

  29/09/23

  1 item of Media coverage

  Press/Media

• Reports from Icahn School of Medicine at Mount Sinai Describe Recent Advances in Multiple Myeloma (High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments)

  Seunghee Kim-Schulze, Adeeb Rahman, Samir Parekh, Hearn Cho & Sacha Gnjatic

  11/09/23

  1 item of Media coverage

  Press/Media

• Findings from Tisch Cancer Institute Broaden Understanding of Myeloma (Sequencing T-cell Redirection Therapies Leads To Deep and Durable Responses In Patients With Relapsed/refractory Myeloma)

  Joshua Richter, Sundar Jagannath, Ajai Chari, Guido Lancman, Samir Parekh & Hearn Cho

  31/05/23

  1 item of Media coverage

  Press/Media

• From Beirut to frontline hematology research

  Tarek Mouhieddine, Samir Parekh & Ajai Chari

  20/04/23

  2 items of Media coverage

  Press/Media

• New Multiple Myeloma Study Findings Recently Were Reported by Researchers at Icahn School of Medicine at Mount Sinai (Interventions and Outcomes of Patients With Multiple Myeloma Receiving Salvage Therapy After Bcma-directed Car T Therapy)

  David Melnekoff, Joshua Richter, Samir Parekh, Sundar Jagannath, Ajai Chari, Tarek Mouhieddine, Cesar Rodriguez & Yogita Ghodke

  13/04/23

  1 item of Media coverage

  Press/Media

• Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myeloma

  Samir Parekh

  22/03/23

  1 item of Media coverage

  Press/Media

• Epigenetic, Immunotherapy Combo Effective in Mantle Cell Lymphoma

  Samir Parekh & Violetta V. Leshchenko

  14/12/22

  1 item of Media coverage

  Press/Media

• Oncotarget | Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

  Samir Parekh & Violetta V. Leshchenko

  13/12/22

  2 items of Media coverage

  Press/Media

• New Findings from Icahn School of Medicine at Mount Sinai Describe Advances in Multiple Myeloma (Trial Designs and Endpoints for Immune Therapies In Multiple Myeloma)

  Joshua Richter, Samir Parekh, Sundar Jagannath, Ajai Chari, Erin Moshier, Guido Lancman, Hearn Cho & Cesar Rodriguez

  8/12/22

  1 item of Media coverage

  Press/Media

• CDK4: A master regulator of the cell cycle and its role in cancer

  E. Premkumar Reddy, Poulikos Poulikakos, Stacey Baker & Samir Parekh

  5/12/22

  3 items of Media coverage

  Press/Media

• Master regulator of cell cycle and its role in cancer

  E. Premkumar Reddy, Poulikos Poulikakos, Samir Parekh & Stacey Baker

  3/12/22

  1 item of Media coverage

  Press/Media

• Genes & Cancer | CDK4: a master regulator of the cell cycle and its role in cancer

  E. Premkumar Reddy, Poulikos Poulikakos, Samir Parekh & Stacey Baker

  2/12/22

  2 items of Media coverage

  Press/Media

• CaMMouflage Study to Evaluate Allogeneic Anti-BCMA CAR T Therapy in Multiple Myeloma

  Sundar Jagannath & Samir Parekh

  21/11/22

  1 item of Media coverage

  Press/Media